NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Forecast, Price & News

$1.22

-0.12 (-8.95%)

(As of 09/20/2023 ET)

Compare

Today's Range: $1.16
▼
$1.34
50-Day Range: $1.22
▼
$3.00
52-Week Range: $1.16
▼
$32.00

Volume: 25,355 shs
Average Volume: 121,500 shs
Market Capitalization: $2.84 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Intelligent Bio Solutions MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
6.51% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$192 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($3.44) to ($2.83) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Intelligent Bio Solutions.

4.0

Short Interest

Percentage of Shares Shorted
6.51% of the float of Intelligent Bio Solutions has been sold short.
Short Interest Ratio / Days to Cover
Intelligent Bio Solutions has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Intelligent Bio Solutions has recently decreased by 33.31%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Intelligent Bio Solutions does not currently pay a dividend.
Dividend Growth
Intelligent Bio Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INBS.

2.8

News and Social Media Coverage

News Sentiment
Intelligent Bio Solutions has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
MarketBeat Follows
2 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Intelligent Bio Solutions insiders have bought more of their company's stock than they have sold. Specifically, they have bought $192.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 1.09% of the stock of Intelligent Bio Solutions is held by insiders.
Percentage Held by Institutions
Only 9.28% of the stock of Intelligent Bio Solutions is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($3.44) to ($2.83) per share.
Price to Book Value per Share Ratio
Intelligent Bio Solutions has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Intelligent Bio Solutions (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

INBS Price History

30 days | 90 days | 365 days | Advanced Chart

INBS Stock News Headlines

September 13, 2023 | americanbankingnews.com

Financial Survey: Intelligent Bio Solutions (NASDAQ:INBS) and Nyxoah (NASDAQ:NYXH)

September 8, 2023 | finance.yahoo.com

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

September 21, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

September 5, 2023 | finance.yahoo.com

INBS: Australia Off to a Strong Start

August 25, 2023 | benzinga.com

Intelligent Bio Solutions (NASDAQ: INBS) Launches Global Expansion of Its Cutting-Edge Intelligent Drug Screening System

August 1, 2023 | finance.yahoo.com

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

August 1, 2023 | finance.yahoo.com

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

July 25, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc.'s (NASDAQ:INBS) Profit Outlook

September 21, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

July 11, 2023 | ecampusnews.com

Leveraging AI to Power Today’s Intelligent Campus

July 6, 2023 | finance.yahoo.com

Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order

June 28, 2023 | finance.yahoo.com

Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge

June 22, 2023 | au.finance.yahoo.com

INBS - Intelligent Bio Solutions Inc.

June 20, 2023 | finance.yahoo.com

Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million

June 5, 2023 | finance.yahoo.com

INBS: Fentanyl is the Latest Innovation

May 24, 2023 | finance.yahoo.com

Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th

May 16, 2023 | finance.yahoo.com

Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution

May 12, 2023 | finanznachrichten.de

Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights

May 11, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights

May 2, 2023 | finance.yahoo.com

Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility

April 28, 2023 | marketwatch.com

UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions' Portable Fingerprint Drug Testing Solution

April 26, 2023 | finance.yahoo.com

UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution

April 18, 2023 | finance.yahoo.com

Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader

March 30, 2023 | wsj.com

Intelligent Bio Solutions Inc.

March 27, 2023 | finance.yahoo.com

A & F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program

March 13, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia

March 10, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants

See More Headlines

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Company Calendar

Last Earnings: 8/24/2023
Today: 9/20/2023
Next Earnings (Estimated): 11/23/2023
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:INBS
CUSIP: N/A
CIK: 1725430
Web: gbs.inc
Phone: 646-828-8258
Fax: N/A
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,630,000.00
Net Margins: N/A
Pretax Margin: -848.45%
Return on Equity: -104.58%
Return on Assets: -53.15%

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 0.66
Quick Ratio: 0.49

Sales & Book Value

Annual Sales: $1.26 million
Price / Sales: 2.26
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.58 per share
Price / Book: 0.77

Miscellaneous

Outstanding Shares: 2,330,000
Free Float: 2,305,000
Market Cap: $2.84 million
Optionable: Not Optionable
Beta: 3.69

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Harry Simeonidis (Age 56)
Pres & CEO
Comp: $310.79k

Mr. Spiro Kevin Sakiris B.Bus (Age 61)
C.A., CA, Dip Law, Chief Financial Officer
Comp: $274.43k

Ms. Victoria Gavrilenko (Age 40)
Operations Mang.

Mr. Alex Arzeno
VP of Investor Relations

Key Competitors

View All Competitors

Insiders

Harry Simeonidis
Bought 100 shares on 8/31/2023
Total: $192.00 ($1.92/share)

View All Insider Transactions

INBS Stock - Frequently Asked Questions

How have INBS shares performed in 2023?: Intelligent Bio Solutions' stock was trading at $3.9980 at the start of the year. Since then, INBS stock has decreased by 69.5% and is now trading at $1.2201.
View the best growth stocks for 2023 here.
Are investors shorting Intelligent Bio Solutions?: Intelligent Bio Solutions saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 98,900 shares, a decline of 33.3% from the August 15th total of 148,300 shares. Based on an average daily trading volume, of 52,500 shares, the days-to-cover ratio is currently 1.9 days. Currently, 6.5% of the company's shares are short sold.
View Intelligent Bio Solutions' Short Interest.
When is Intelligent Bio Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 23rd 2023.
View our INBS earnings forecast.
How were Intelligent Bio Solutions' earnings last quarter?: Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its earnings results on Thursday, August, 24th. The company reported ($1.91) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.66) by $0.25. The firm earned $0.44 million during the quarter, compared to analyst estimates of $0.49 million.

When did Intelligent Bio Solutions' stock split?: Shares of Intelligent Bio Solutions reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What is Intelligent Bio Solutions' stock symbol?: Intelligent Bio Solutions trades on the NASDAQ under the ticker symbol "INBS."
How do I buy shares of Intelligent Bio Solutions?: Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Intelligent Bio Solutions' stock price today?: One share of INBS stock can currently be purchased for approximately $1.22.
How much money does Intelligent Bio Solutions make?: Intelligent Bio Solutions (NASDAQ:INBS) has a market capitalization of $2.84 million and generates $1.26 million in revenue each year.
How can I contact Intelligent Bio Solutions?: Intelligent Bio Solutions' mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The official website for the company is gbs.inc. The company can be reached via phone at 646-828-8258 or via email at investor.relations@gbs.inc.

This page (NASDAQ:INBS) was last updated on 9/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial